Advertisement AtCor Medical signs new clinical trial contracts - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

AtCor Medical signs new clinical trial contracts

AtCor Medical, a medical device company, has signed two new contracts to supply SphygmoCor systems and clinical trial support services to leading international pharmaceutical companies.

These contracts are with existing clients and have a minimum value of $635,000 and $200,000 respectively. They bring the total value of US pharmaceutical clinical trials contracts secured over the past 10 months to $7.3 million.

Duncan Ross, CEO of AtCor Medical, said: “These contracts from existing customers to support new clinical trials demonstrate the importance of noninvasive central blood pressure data in drug development and the high quality of the services we provide.”